OncoBEAM™ RAS CRC Kit offers the following advantages:

  • High Concordance with Tissue
    OncoBEAM™ RAS CRC Kit demonstrated an overall percent agreement of 93.3 % with tissue
  • Safety and Convenience
    Minimally invasive, few risks
  • Accurate Information
    Blood sample evaluation represents current mutational status of patient’s disease; Information of tumor dynamics in real time
  • No Selection Bias
    Evaluate primary tumor and metastases with one sample
  • Ability to Monitor
    Allows multiple measurements to assess drug response and resistance
  • Time Sensitive
    Rapid turnaround time from biopsy to result

Please help us to serve you better by sharing your experience.

Do you find the resources provided at this site useful?

What scientific topics you would be most interested to read?